---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-25-000036"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T01:26:14.317905+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q3 non-GAAP EPS $2.35, up 13% YoY; raises FY25 EPS guidance to $8.05-$8.15

## Summary
- Revenue $54.9B flat YoY; up 19% ex-customer contract expiration.
- GAAP diluted EPS $2.10; non-GAAP $2.35, up 13% on 21% non-GAAP op earnings growth.
- Pharma & Specialty segment profit $662M (+14%); Medical segment profit $39M (+77%).
- FY25 non-GAAP EPS guidance raised to $8.05-$8.15 from $7.85-$8.00.
- Completed acquisition of Advanced Diabetes Supply Group on Apr 1; $375M ASR program executed.

## SEC filing metadata
- accession: 0000721371-25-000036
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/0000721371-25-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/cah-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-25-000036
- JSON: https://secwatch.observer/filing/0000721371-25-000036.json
- Plain text: https://secwatch.observer/filing/0000721371-25-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.